BeStock  
Stocks › Biotechnology › SLN

Silence Therapeutics SLN

US equityMarket cap rank #3022Biotechnology
$19.81 +$0.00 (0.00%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $19.81 0.00%
Open$19.81
Prev close$19.81
Day range$19.80 – $19.83
Volume399.1K
Market cap$1.23B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$0.00-100.0% YoY
Operating profit-$14.22M+45.8% YoY
Net profit-$12.43M+40.7% YoY
Diluted EPS-$0.24+46.7% YoY
Free cash flow-$12.78M-17.3% YoY
Operating cash flow-$12.78M

Revenue, last 8 quarters

$25.3MDec '24$142.0KMar '25$224.0KJun '25$159.0KSep '25$34.0KDec '25$422.0KMar '26$0.0Jun '26$0.0Sep '26

Net profit, last 8 quarters

$12.3MDec '24$-28.5MMar '25$-27.4MJun '25$-21.0MSep '25$-11.8MDec '25$-15.0MMar '26$-12.3MJun '26$-12.4MSep '26

Diluted EPS by quarter

0.27Dec '24-0.60Mar '25-0.57Jun '25-0.45Sep '25-0.27Dec '25-0.33Mar '26-0.27Jun '26-0.24Sep '26

Free cash flow by quarter

$-27.5MDec '24$-12.3MMar '25$-21.8MJun '25$-10.9MSep '25$-17.3MDec '25$-15.6MMar '26$1.5MJun '26$-12.8MSep '26

Annual revenue

$7.5MFY20$16.8MFY21$21.7MFY22$31.6MFY23$43.3MFY24$559.0KFY25

Profitability & balance sheet

Gross margin95.0%
Operating margin-12,343.6%
Net margin-11,276.5%
Return on equity-35.6%
Return on assets-24.0%
Return on invested capital-35.5%
Current ratio23.94
Liabilities / assets23.6%
Cash & investments$247.66M
Total debt$0.00
Net cash (debt)$247.66M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $0.00 $0.00 $422,000.00 $559,000.00 $34,000.00
Total Operating Revenue $0.00 $0.00 $422,000.00 $559,000.00 $34,000.00
Cost of Revenue $0.00 $0.00 $11,000.00 $215,000.00 $12,000.00
Gross Profit $0.00 $0.00 $411,000.00 $344,000.00 $22,000.00
Operating Expense $14.22M $13.87M $16.15M $90.10M $12.48M
Selling and Admin Expenses $4.92M $4.72M $7.03M $22.34M $3.73M
-General & Admin Expense $4.92M $4.72M $7.03M $22.34M $3.73M
Research & Development $9.30M $9.15M $9.12M $67.75M $8.75M
Operating Profit -$14.22M -$13.87M -$15.74M -$89.75M -$12.46M
Other Income (Expense) $1.80M $1.60M $780,000.00 -$2.33M -$2.79M
Gain on Sale of Security $21,000.00 $151,000.00 -$482,000.00 -$8.47M -$19,000.00
Special Income (Charges) $0.00 $0.00 – -$1.32M $0.00
-Less:Restructuring and Mergern & Acquisition $0.00 $0.00 – $1.32M $0.00
Other Non-Operating Income (Expenses) $1.78M $1.45M $1.26M $7.46M -$2.77M
Pretax Profit -$12.43M -$12.27M -$14.96M -$88.60M -$11.77M
Tax $0.00 $1,000.00 $0.00 $11,000.00 $0.00
Net Profit -$12.43M -$12.27M -$14.96M -$88.61M -$11.77M
Profit from Continuing Operations -$12.43M -$12.27M -$14.96M -$88.61M -$11.77M
Net Income to Parent Company -$12.43M -$12.27M -$14.96M -$88.61M -$11.77M
Net Income to Common Stockholders -$12.43M -$12.27M -$14.96M -$88.61M -$11.77M
Basic EPS -$0.24 -$0.27 -$0.33 -$1.89 -$0.27
Diluted EPS -$0.24 -$0.27 -$0.33 -$1.89 -$0.27
Net Non-Operating Interest Income (Expense) – – – $3.48M –
Non-Operating Interest Income – – – $3.48M –

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $281.50M $106.41M $115.12M $131.44M $131.44M
Total Current Assets $269.58M $94.28M $102.85M $118.66M $118.66M
Cash and Cash Equivalents & Short-Term Investments $247.66M $72.05M $70.08M $85.11M $85.11M
-Cash and Cash Equivalents $247.66M $72.05M $5.66M $11.28M $11.28M
-Short Term Investments $0.00 $0.00 $64.42M $73.84M $73.84M
Receivables $9.97M $9.29M $22.22M $24.61M $24.61M
-Other Receivables $9.97M $9.29M $22.22M $22.01M $22.01M
Other Current Assets $11.94M $12.94M $10.56M – –
Total Non-Current Assets $11.92M $12.13M $12.27M $12.78M $12.78M
Net PPE $1.31M $1.44M $1.54M $1.75M $1.75M
-Gross PPE $1.31M $1.44M $1.54M $5.71M $5.71M
Goodwill and Other Intangible Assets $10.48M $10.56M $10.61M $10.91M $10.91M
-Goodwill $10.25M $10.33M $10.36M $10.62M $10.62M
-Other Intangible Assets $227,000.00 $237,000.00 $248,000.00 $288,000.00 $288,000.00
Other Non-Current Assets $127,000.00 $127,000.00 $127,000.00 – –
Total Liabilities $66.48M $67.94M $65.72M $69.14M $69.14M
Total Current Liabilities $11.26M $12.71M $10.46M $13.61M $13.61M
Payables $11.17M $12.61M $10.37M $4.64M $4.64M
-Accounts Payable $11.17M $12.61M $10.37M $4.41M $4.41M
Short-Term Debt and Capital Lease Obligation $87,000.00 $103,000.00 $93,000.00 $89,000.00 $89,000.00
-Current Capital Lease Obligation $87,000.00 $103,000.00 $93,000.00 $89,000.00 $89,000.00
Current Deferred Liabilities $0.00 $0.00 $0.00 $168,000.00 $168,000.00
Total Non-Current Liabilities $55.22M $55.23M $55.26M $55.53M $55.53M
Long Term Debt and Capital Lease Obligation $0.00 $9,000.00 $43,000.00 $71,000.00 $71,000.00
-Long Term Capital Lease Obligation $0.00 $9,000.00 $43,000.00 $71,000.00 $71,000.00
Non-Current Deferred Liabilities $55.22M $55.22M $55.22M $55.45M $55.45M
Total Equity $215.02M $38.47M $49.40M $62.30M $62.30M
Stockholders' Equity $215.02M $38.47M $49.40M $62.30M $62.30M
Capital Stock $13.33M $10.29M $10.29M $10.29M $10.29M
-Common Stock $13.33M $10.29M $10.29M $10.29M $10.29M
Additional Paid-In Capital $807.06M $621.15M $620.01M $617.56M $617.56M
Retained Earnings -$601.89M -$589.63M -$577.53M -$562.57M -$562.57M
Gains/Losses Not Affecting Retained Earnings -$3.48M -$3.34M -$3.37M -$2.98M -$2.98M
-Accounts Receivable – – $0.00 $0.00 $0.00
-Taxes Receivable – – – $2.61M $2.61M
Prepaid Assets – – – $8.93M $8.93M
-Accumulated Depreciation – – – -$3.96M -$3.96M
Non-Current Prepaid Assets – – – $127,000.00 $127,000.00
-Total Tax Payable – – – $234,000.00 $234,000.00
Current Accrued Expenses – – – $5.75M $5.75M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$12.78M $1.52M -$15.60M -$62.27M -$17.29M
Net cash flow from continuing operations -$12.78M $1.52M -$15.60M -$62.27M -$17.29M
Net Income from Continuing Operations -$12.43M -$12.27M -$14.96M -$88.61M -$11.77M
Gain/Loss from Continuing Operations -$79,000.00 $178,000.00 -$25,000.00 $11.02M $230,000.00
Depreciation & Depletion & Amortization $106,000.00 $108,000.00 $106,000.00 $555,000.00 $113,000.00
Deferred Tax $0.00 – – $11,000.00 $0.00
Other Non-Cash Items $0.00 -$584,000.00 -$519,000.00 -$3.48M -$880,000.00
Change in Working Capital -$1.15M $12.78M -$2.66M $10.16M -$4.89M
-Change in Receivables -$681,000.00 $12.92M -$209,000.00 $5.07M $220,000.00
-Change in Payables and Accrued Expense -$1.44M $2.20M -$2.95M -$4.08M -$3.58M
-Change in Other Current Assets $991,000.00 -$2.33M $931,000.00 $9.67M -$1.48M
-Change in Other Current Liabilities -$25,000.00 -$24,000.00 -$24,000.00 -$168,000.00 -$22,000.00
-Change In Other Working Capital $0.00 $0.00 -$404,000.00 -$334,000.00 -$32,000.00
Net cash flow from investing $0.00 $64.94M $10.00M -$47.99M -$53.34M
Net Cash Flow from Continuing Investing Activities $0.00 $64.94M $10.00M -$47.99M -$53.34M
Net PPE Purchase and Sale $0.00 $0.00 $0.00 -$55,000.00 $0.00
Net Investment Purchase and Sale $0.00 $64.94M $10.00M -$47.94M -$53.34M
Financing Cash Flow $188.33M $2,000.00 $0.00 $15,000.00 $0.00
Net Cash Flow from Continuing Financing Activities $188.33M $2,000.00 $0.00 $15,000.00 $0.00
Net Common Stock Issuance $188.33M $2,000.00 $0.00 $15,000.00 $0.00
Ending Cash Balance $247.66M $72.05M $5.66M $11.28M $11.28M
Net Change in Cash $175.56M $66.46M -$5.60M -$110.25M -$70.63M
Beginning Cash Balance $72.05M $5.66M $11.28M $121.33M $82.03M
Effect of Exchange Rate Changes $48,000.00 -$63,000.00 -$17,000.00 $195,000.00 -$129,000.00
Free Cash Flow -$12.78M $1.52M -$15.60M -$62.33M -$17.29M

Discussion

No comments yet — be the first to weigh in on SLN.

Sign in to join the discussion.

Scroll to Top